These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24183773)

  • 1. Automated profile review for transdermal fentanyl to verify opioid tolerance in the military health system.
    Devine JW; Trice S; Nwokeji E; Yarger S; Anekwe TM; Davies W; Lawrence J
    Mil Med; 2013 Nov; 178(11):1241-4. PubMed ID: 24183773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why are US military personnel prescribed transdermal fentanyl patches?
    Murray H; Gregoriou AN; Lepore A; Booth GJ; Goldman AH; Allen ML; Balazs GC
    BMJ Mil Health; 2023 Aug; 169(4):335-339. PubMed ID: 34625516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the fentanyl patch-for-patch program in Ontario, Canada.
    Tadrous M; Greaves S; Martins D; Nadeem K; Singh S; Mamdani MM; Juurlink DN; Gomes T
    Int J Drug Policy; 2019 Apr; 66():82-86. PubMed ID: 30743092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of prior opioid tolerance among new users of fentanyl transdermal system in FDA's Sentinel System.
    Cocoros NM; Larochelle MR; Popovic J; Petrone AB; Kornegay C; Ju J; Racoosin JA
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):112-116. PubMed ID: 30379379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.
    Ripamonti C; Fagnoni E; Campa T; Brunelli C; De Conno F
    Support Care Cancer; 2006 May; 14(5):400-7. PubMed ID: 16485087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
    Tawfik MO; Bryuzgin V; Kourteva G;
    Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a six-hour continuous overlap method for converting intravenous to transdermal fentanyl in cancer pain.
    Samala RV; Bloise R; Davis MP
    J Pain Symptom Manage; 2014 Jul; 48(1):132-6. PubMed ID: 24291296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F; Chowdhury S; Shelley M; Williams G
    Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilisation of transdermal fentanyl in Germany from 2004 to 2006.
    Garbe E; Jobski K; Schmid U
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):191-8. PubMed ID: 21681850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of breakthrough pain with fentanyl buccal tablet in opioid-tolerant patients with chronic pain: appropriate patient selection and management.
    Fine PG; Narayana A; Passik SD
    Pain Med; 2010 Jul; 11(7):1024-36. PubMed ID: 20642730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK.
    Guest JF; Ruiz FJ; Russ J; Gupta RD; Mihai A; Greener M
    Curr Med Res Opin; 2005 Feb; 21(2):271-80. PubMed ID: 15801998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research from the Palliative Care Department in Poznań on treatment of neoplasm pain with Durogesic (transdermal fentanyl)].
    Leppert W; Luczak J; Gorzelińska L; Kozikowska J
    Przegl Lek; 2000; 57(1):59-64. PubMed ID: 10907375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
    Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough strong opioid analgesia prescription in patients using transdermal fentanyl admitted to a hospice.
    Lawrie I; Lloyd-Williams M; Waterhouse E
    Am J Hosp Palliat Care; 2003; 20(3):229-30. PubMed ID: 12785045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should we use transdermal fentanyl (TF) for pain management in palliative care patients?
    Fainsinger RL; Bruera E
    J Palliat Care; 1996; 12(1):48-53. PubMed ID: 8857249
    [No Abstract]   [Full Text] [Related]  

  • 18. Converting to transdermal fentanyl: avoidance of underdosing.
    Bradley AM; Valgus JM; Bernard S
    J Palliat Med; 2013 Apr; 16(4):409-11. PubMed ID: 23477303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System.
    Wiegand TJ; Le Lait MC; Bartelson BB; Dart RC; Green JL
    J Pain; 2016 Jun; 17(6):745-52. PubMed ID: 26996928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National utilization of transdermal fentanyl among community-dwelling older people in Finland.
    Bell JS; Klaukka T; Ahonen J; Hartikainen S
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):355-61. PubMed ID: 20129256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.